Leadership

Jim Jones, Founder
For nearly four decades, Jim has pioneered the development of groundbreaking technologies and innovative products in the areas of information technology, mobile computers, functional nano-materials, additive manufacturing, and consumer healthcare.
Jim is the founder of five technology-based companies. He has also served on the boards of directors of two privately held technology companies, a major university engineering foundation, and the Congressional Internet Caucus. He led the turnaround and sale of a handheld-computer company, acquired the technology assets of two mobile computer companies, and received patents for the design of the first mobile e-commerce computers. More recently, Jim developed a nano-coating process that substantially extends the operational life of critical electro-mechanical components used in commercial, industrial, and military applications.
His innovations also include:
1. Design and implementation of worldwide computer networks that manage the door-to-door movement of billions of packages each year.
2. Advancements in handheld and tablet computers.
3. Processing tobacco plants into a clean dry biofuel.
4. Design of an advanced wireless spirometer for sufferers of asthma and COPD.
5. The development of a wireless digital classroom teaching system that was previewed by request to senior members of Congress and The White House.
Jim served six years on the Advisory Committee to the Congressional Internet Caucus (CIC) at the request of co-chairman Senator Conrad Burns. The CIC is composed of members of the U.S. House and Senate focused on developing the potential benefits of the Internet and other technologies related to national interests.
As an undergraduate at North Carolina State University, Jim focused on mechanical engineering, nuclear engineering, and business economics. He later attended the UNC-Chapel Hill Graduate School of Business Administration as a North Carolina Business Foundation Fellow, a full-tuition merit-based award. Jim is one of only four students elected twice as president of the NCSU engineering student body since 1926. He is also a Knight of the Order of St. Patrick, an engineering honorary society, and the only recipient of the Dean's Special Merit Award from the NCSU School of Engineering in its 135-year history.
The motivation for SEAL-D was the death of Jim's mother caused by Clostridium Difficile (C.diff), a deadly bacteria that primarily infects the elderly and the very young. Found predominantly in extended living facilities and hospitals, C.diff cannot be killed by alcohol-based sanitizers. C.diff is easily picked up by touching an infected surface with the hands, such as eating utensils, where it then enters the digestive tract through the mouth. If not repelled by the body's immune system, it can cause death within 10 weeks. According to the Centers for Disease Control, C.diff infects an estimated 450,000 people and causes 30,000 deaths annually. Although well-known in the healthcare and extended-living communities, there is no vaccine or known cure once it infects the digestive system. The only solution is to kill the bacterium before it enters.
Jim’s quest led to the introduction of SEAL-D, a product proven to kill 99.9999% of the C.diff bacterium on the skin and other surfaces within the first 20 seconds, along with many other harmful bacteria and viruses. Its active ingredient is the only non-alcohol ingredient allowed by the FDA. Both SEAL-D and its US-based manufacturing facility are FDA-registered and monitored.
SEAL-D is dedicated to the memory of Jim's mother and to all families that have suffered similar losses.

Dr. Mike Buch, Senior Advisor
Mike Buch holds B.A., M.S., and Ph.D. degrees in Analytical Chemistry and Biotechnology and nearly three decades of experience in the consumer healthcare industry with some of the world’s leading companies. Before joining the SEAL-D team, Mike served as Chief Science Officer for a multibillion-dollar global consumer healthcare company, responsible for leading Research, Development, Product Management, and Regulatory and Quality Assurance. Prior, he held increasingly responsible positions with the largest consumer healthcare company, GSK Consumer Healthcare, where he advanced from Director of Strategic Growth Initiatives, to Director of Global Innovations, and finally to Senior Director of Scientific Strategy.
Mike's leadership includes strategic development programs, open innovation programs, licensing programs, consumer healthcare R&D, advanced technologies labs, advanced optical analysis labs, and biosensor design and research.
Mike is directly responsible for the development of more than 100 consumer healthcare products that generate more than $4 billion annually in more than 100 countries, including Listerine, Lubriderm, Aquafresh Toothpaste, Aquafresh White Trays, Pronamal Toothpaste, Benadryl, and the EPT Home Pregnancy Test.
Mike also produced more than a dozen patents in the healthcare field, along with several books and numerous articles published in peer-reviewed journals.
Before his passing in 2022, Mike was a member of the highly respected American Chemical Society, The New York Academy of Science, and the American Association for the Advancement of Science. From 2019 to 2022, Mike served as a Board Member of the Institute on Science for Global Policy.